Drawing for Serial No. 77807884

USPTO serial 77807884

Serial No. 77807884

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
STEIN, JAMES W
Law office
TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with Serial No. 77807884?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Laurence P. Colton

LAURENCE P. COLTON SMITH, GAMBRELL & RUSSELL, LLP1230 PEACHTREE ST NE STE 3100ATLANTA, GA 30309-3592UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations; Pharmaceutical preparations for loading medical devices and implants, namely, naturally-found bioactive compounds that can promote or inhibit a desirable therapeutic response, synthetically-made bioactive compounds that can promote or inhibit a desirable therapeutic response, biologics, namely sugars, proteins, and nucleic acids that can promote or inhibit a desirable therapeutic response, radioactive or other marker molecules that can be incorporated into medical devices and implants to track their site of localization in vivo, organic dyes that can be incorporated into medical devices and implants to add pigments that can be detectable visually or by instrumentation, and organic dyes that can be incorporated into medical devices and implants to add pigments that can be detectable visually or by instrumentationACTIVE—
010Medical devices; Medical devices and implants, namely, polymeric-coated medical devices and polymeric coated implants used with or without loading naturally-found bioactive compounds, synthetically-made bioactive compounds, biologics, radioactive or other marker molecules, organic dyes, and/or inorganic dyes; medical devices and implants, namely, polymeric-coated particles for embolization, polymeric-coated embolic protection devices, polymeric-coated vascular and nonvascular stents, polymeric-coated embolic protection devices, polymeric-coated catheters, polymeric-coated artificial vascular and nonvascular vessels, polymeric-coated syringes, polymeric-coated wound dressings and topically applied bandages, polymeric-coated matrix for providing mechanical support for tissue-reconstruction and for pharmaceutical preparations, polymeric-coated stent grafts, polymeric-coated tubings, polymeric-coated woven and nonwoven medical textiles for tissue reconstruction, polymeric-coated dermal fillers, polymeric-coated breast implants, polymeric-coated tissue fasteners or abutments for tissue reconstruction, polymeric-coated orthopedic implant devices, polymeric-coated arterial and venous access devices and delivery devices, namely, pic lines, dialysis catheters, and AV ports, and polymeric-coated woven and nonwoven fabrics for ex vivo uses, namely, operating gowns, fabrics for protective clothing, and material for making diapersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jul 6, 2010MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 6, 2010ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 3, 2009GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 3, 2009GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 3, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 23, 2009DOCKASSIGNED TO EXAMINER—
Aug 25, 2009MDSMNOTICE OF DESIGN SEARCH CODE MAILED—
Aug 24, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 24, 2009NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance